Heart disease study: do aspirin and clopidogrel quiet the immune system?
NCT ID NCT07169513
First seen Nov 01, 2025 · Last updated Jun 06, 2026 · Updated 31 times
Summary
This study looks at whether two common anti-clotting drugs, aspirin and clopidogrel, can reduce inflammation in people with silent atherosclerosis (hardening of the arteries without symptoms). Researchers will measure how these drugs affect clusters of blood cells called monocyte-platelet aggregates, which are linked to worsening heart disease. The study involves 60 adults with hidden artery disease and aims to understand how these medications work on inflammation, not to treat or cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.